Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consent Decree Orders FDA Action On Triclosan OTC Monographs

This article was originally published in The Tan Sheet

Executive Summary

A Nov. 21 consent decree sets multiple deadlines over a five-year period to make FDA finalize its OTC topical antimicrobial drug products monograph with respect to triclosan. Under one deadline of note to triclosan product makers, the agency must publish a tentative final monograph for consumer antiseptic hand wash products by Dec. 16, with a final monograph due by Sept. 15, 2016.

Advertisement

Related Content

Here's The 'Rub' On Antiseptic Washes: FDA Wants Additional Safety, Efficacy Data
Cold Indication For Antihistamine Monograph Expected This Year – DNDP Director Michele
Industry Groups Need FDA Input On Antibacterial Ingredient Studies
OTC Monograph System Needs Transparency, Communication – PCPC
NRDC Sues FDA For Details On Triclosan In 1997 Colgate Total Approval
In Brief: Clearblue estimates weeks, Barry Meltzer dies, P&G eliminating phthalates and triclosan, NPLEx adds Delaware
Cold Indication For Antihistamines Targeted In Regulatory Agenda
Triclosan Does Not Contribute To Antibacterial Resistance – Study
Triclosan Concern In Congress Spurs Call For Final Antimicrobial Monograph

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106739

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel